PANTERA | LinkedIn (original) (raw)
Pharmaceutical Manufacturing
Mol, Flemish Region 4,443 followers
A Better Fight for Life
About us
PanTera aims to secure the large-scale production of actinium-225 (225Ac), one of the most promising alpha-emitting radioisotopes to fight cancers by Targeted RadioTherapy (TRT). By working towards this large-scale production, PanTera’s ultimate goal is to improve the accessibility of future innovative cancer therapy based on 225Ac and theranostics in general.
Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
Mol, Flemish Region
Type
Partnership
Founded
2022
Locations
Employees at PANTERA
Updates
- PANTERA reposted this
A big thank you to the PANTERA team for three intensive and inspiring days focused on developing the best solutions for large-scale Ac-225 production. We are thrilled to make this exciting new journey together! #ComecerForRadiopharma - PANTERA reposted this
🧬⚛️Happening this week: Second International Workshop on Medical Radioisotopes Supply ⚛️🧬 The OECD Nuclear Energy Agency gathered governmental decision makers, private sector representatives, health organisations and researchers to chart the development of secure supply chains for conventional and innovative nuclear radioisotopes in the medical field. 🌍 Co-organised with the U.S. Department of Energy (DOE) and the European Commission’s Joint Research Centre, the 2024 edition in Paris adds a focus on the market potential of Lutetium-177 (Lu-177), Actinium (Ac-225) and other innovative medical radioisotopes, strengthening the medical radioisotope supply chain’s resiliency through monitoring supply and demand and critical infrastructure needs across medical systems. 🏥💉 More about the event 🖱️ https://lnkd.in/ecqM8RMP - Congratulations to our close colleagues at TerraPower Isotopes for accomplishing this ! This provides major reassurance to everyone active in Actinium-225 based radiopharmaceutical development ! No more RayzeBio-style shortages hindering progress in clinical trials or preclinical research! We should recognize the pioneering work done by national labs in the Actinium-225 space, but sustainable supply requires commercial actors to engage in the domain !
President and CEO at TerraPower, LLC
1mo
I'm thrilled to share that TerraPower Isotopes is the first commercial-scale provider of actinium-225, and is actively providing this rare isotope for use by drug developers in human clinical trials for targeted cancer treatments. Actinium-225 is a starting material for radiopharmaceuticals that can precisely target cancer cells while minimizing damage to healthy tissue. This is a game-changing advancement for the future of cancer treatment. Read more with the link in the comments below.#NuclearMedicine #HealthcareInnovation #Actinium225 #CancerTreatment #TerraPowerIsotopes - PANTERA reposted this
Senior Project Manager bij TRACTEBEL - ENGIE GROUP
1mo
💥We're proud to contribute our infrastructure and nuclear expertise to the design and construction of Pantera's groundbreaking cancer research facility in Belgium. 👉Learn more about Tractebel’s role in this innovative project https://lnkd.in/eqWNDEDv hashtag#cancerresearch hashtag#nucleartechnology hashtag#innovation hashtag#healthcare hashtag#tractebelurbaneers hashtag#pantera
4,443 followers
2mo Edited
PanTera proudly announces the successful closure of a €134 million funding round, comprising equity, debt, and loan conversions. The oversubscribed €93 million equity round marks the largest Series A funding round ever in Life Science in Belgium, a testament to our compelling vision and execution plan. We are honoured by the trust of the investor consortium led by EQT Life Sciences, with Kurma Partners, Eurazeo, Paladin, Korys, and PMV as followers. With this financing secured, PanTera is now fully funded to complete its game-changing venture, enabling the large-scale, dependable supply of Actinium-225 in time for the anticipated commercialization of Actinium-based radiopharmaceuticals. Our team is strongly motivated by the prospect of creating access for hundreds of thousands of cancer patients to innovative nuclear medicine treatments that offer a better fight for a higher quality life. PanTera wants to express its deep gratitude for the unwavering support of its founding shareholders, SCK CEN and IBA, and acknowledges the early financial contribution of SFPIM. Furthermore, PanTera appreciates the efforts of KBC Securities and Cambrian in facilitating this transaction and thanks KBC Bank & Verzekering, Belfius and GIGARANT for collaborating on the debt financing. Read more at https://lnkd.in/etGuZ39U and https://lnkd.in/eHH7Aeui #actinium #radiopharmaceuticals #TAT #isotope #radioisotope #nuclear #medicine
News - Pantera pantera-life.com -
4,443 followers
2mo Edited
PanTera proudly announces the successful closure of a €134 million funding round, comprising equity, debt, and loan conversions. The oversubscribed €93 million equity round marks the largest Series A funding round ever in Life Science in Belgium, a testament to our compelling vision and execution plan. We are honoured by the trust of the investor consortium led by EQT Life Sciences, with Kurma Partners, Eurazeo, Paladin, Korys, and PMV as followers. With this financing secured, PanTera is now fully funded to complete its game-changing venture, enabling the large-scale, dependable supply of Actinium-225 in time for the anticipated commercialization of Actinium-based radiopharmaceuticals. Our team is strongly motivated by the prospect of creating access for hundreds of thousands of cancer patients to innovative nuclear medicine treatments that offer a better fight for a higher quality life. PanTera wants to express its deep gratitude for the unwavering support of its founding shareholders, SCK CEN and IBA, and acknowledges the early financial contribution of SFPIM. Furthermore, PanTera appreciates the efforts of KBC Securities and Cambrian in facilitating this transaction and thanks KBC Bank & Verzekering, Belfius and GIGARANT for collaborating on the debt financing. Read more at https://lnkd.in/etGuZ39U and https://lnkd.in/eHH7Aeui #actinium #radiopharmaceuticals #TAT #isotope #radioisotope #nuclear #medicine
News - Pantera pantera-life.com - Wij zijn op zoek naar een nieuwe Account Manager in Mol, Flemish Region (#hiring). Solliciteer vandaag nog of deel deze bijdrage met uw netwerk.
-
4,443 followers
2mo Edited
Will we meet you at 19th International Workshop on Targetry and Target Chemistry | WTTC19Samy Bertrand and Blake Tamboline will be there, together with SCK CEN Experts Andrew Cea, Dominic Maertens and Willem Leysen 📅 26-30 August 2024 📍 German Cancer Research Center | Heidelberg, Germany ➤ Booth 13 - Wij zijn op zoek naar een nieuwe Administrative Assistant in Mol, Flemish Region (#hiring). Solliciteer vandaag nog of deel deze bijdrage met uw netwerk.
- Meet us at the 3ʳᵈ Targeted Radiopharmaceuticals Summit US! Do you want to learn more about the Pantera's early supply of ²²⁵Ac through the ²²⁹Th generator route? Are you curious about our timeline for the commercial supply? 👉Don't miss our conference session with Sven Van den Berghe on Wednesday at 12.15 pm. Let's discuss to drive innovation together! #PanTera #actinium225 #Ac225 #radiopharmaceuticals #thorium229
Join now to see what you are missing
Similar pages
- Radiant Biotherapeutics Biotechnology Research Toronto, ON
- Candid Therapeutics Biotechnology Research San Diego, CA
- SCK CEN Research Services Mol, Vlaanderen
- Superluminal Medicines Inc. Biotechnology Research Boston, Massachusetts
- ONL Therapeutics Biotechnology Research Ann Arbor, Michigan
- SpectraWAVE, Inc. Medical Equipment Manufacturing Bedford, MA
- Oruka Therapeutics Biotechnology Research
- Terns Pharmaceuticals Biotechnology Research Foster City, California
- MBX Biosciences, Inc. Biotechnology Research Carmel, IN
- Centessa Pharmaceuticals Biotechnology Research